Sofosbuvir/ledipasvir improved patient-reported outcomes in HCV
BOSTON - A hepatitis C treatment regimen of sofosbuvir and ledipasvir without ribavirin is associated with significant improvement in patient-reported outcomes, new research suggests.<br...